Trials / Conditions / Non-small Cell Lung Cancers
Non-small Cell Lung Cancers
5 registered clinical trials studyying Non-small Cell Lung Cancers.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With NCT06682806 | Prelude Therapeutics | Phase 2 |
| Terminated | Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib NCT06130254 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 M NCT05639751 | Prelude Therapeutics | Phase 1 |
| Completed | A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors NCT05538572 | Prelude Therapeutics | Phase 1 |
| Unknown | Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung C NCT01871454 | University of Louisville | Phase 2 |